Antibodies and vascular involvement in inflammatory joint disease: Clinical relevance

Joint Bone Spine

Volumn 68, Issue 6, 2001, Pages 466-476

  Vittecoq, Olivier ^a   Jouen Beades, Fabienne ^a   Tron, François ^a   Le Loët, Xavier ^a  

^a INSERM   (France)

Author keywords

ANCA; Anti phospholipid antibodies; Autoantibodies; Cryoglobulinemia; Inflammatory rheumatic disease; Vascular injury

Indexed keywords

ANTICOAGULANT AGENT; AUTOANTIBODY; BETA2 GLYCOPROTEIN 1; CRYOGLOBULIN; LIPOCORTIN 5; MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PHOSPHOLIPID ANTIBODY;

ALGORITHM; ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; BLOOD VESSEL INJURY; CLINICAL PRACTICE; CRYOGLOBULINEMIA; ENDOTHELIUM CELL; HUMAN; INFLAMMATION; INFLAMMATORY JOINT DISEASE; PATHOGENESIS; REVIEW; RHEUMATIC DISEASE; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VASCULITIS;

EID: 0035679640     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1297-319X(01)00309-8     Document Type: Review

References (69)

1. Classification and epidemiology of systemic vasculitis
2. Sequence homologies between hsp60 and autoantigens
3. Induction of heat shock protein in monocytic cells by oxidized low density lipoprotein
4. Atherosclerosis-related markers in systemic lupus erythematosus patients: The role of humoral immunity in enhanced atherogenesis
5. Nomenclature of systemic vasculitides. Proposal of an international consensus conference
6. Nomenclature and classification of vasculitis: Plus ça change, plus c'est la même chose
7. IgG3 reactive rheumatoid factor in rheumatoid arthritis: Etiologic and pathogenic considerations
8. Are autoantibodies active players or epiphenoma?
9. Antibodies to DNA
10. Early anti-nucleosome autoantibodies from a single MRL+/+ mouse: Fine specificity, V gene structure and pathogenicity
11. Characteristics and pathogenic role of anti-beta2-glycoprotein I single-chain Fv domains: Induction of experimental antiphospholipid syndrome
12. Immunization with anti-neutrophil cytoplasmic antibody (ANCA) induces the production of mouse ANCA and perivascular lymphocyte infiltration
13. Lessons from experimental APS models
14. What is new with anti-neutrophil cytoplasmic antibodies: Diagnostic, pathogenetic and therapeutic implications
15. New developments in the pathogenesis of systemic vasculitis
16. Complement-activating rheumatoid-factor-containing complexes in patients with rheumatoid vasculitis
17. Immune complexes in sera from patients with rheumatoid vasculitis induce polymorphonuclear cell-mediated injury to endothelial cells
18. Complement-mediated inhibition of immune precipitation in rheumatoid vasculitis
19. IgG and IgA antibodies to the collagen-like region of Clq in rheumatoid vasculitis
20. Complement mediated vascular endothelial injury in rheumatoid nodules: A histopathological and immunochemical study
21. Analysis of vascular lesions in murine SLE. I. Association with serologic abnormalities
22. Pathology and pathogenesis of vascular injury in systemic lupus erythematosus
23. Selective pathogenicity of murine rheumatoid factors of the cryoprecipitable IgG3 subclass
24. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition par overexpression of Bcl-2 and Abl
25. 2-glycoprotein I and anticardiolipin antibodies in oxidatively modified low-density lipoprotein uptake by macrophages
26. Anti-endothelial cell antibodies: Only for scientists or for clinicians too?
27. Antineutrophil cytoplasmic antibodies
28. Prospective evaluation of the frequency and clinical significance of anti-neutrophil cytoplasmic and anti-cardiolipin antibodies in community cases of patients with rheumatoid arthritis
29. International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies
30. Biologic and clinical significance of cryoglobulins
31. Hepatitis C virus in patients with cryoglobulinemia type II
32. A role for hepatitis C virus infection in type II cryoglobulinemia
33. Hepatitis C virus and cryoglobulinemia
34. Mixed cryoglobulinemia and hepatitis C virus
35. Les nouvelles cibles des anticorps 'antiphospholipides'
36. Association of anti-β2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in sytemic lupus erythematosus
37. Anticorps anti-phospholipides/cofacteurs
38. Antibody to annexin V has anti-phospholipid and lupus anti-coagulant properties
39. Detection of anti-annexin IV and V antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus
40. Antiphospholipid antibodies, annexin V, and pregnancy loss
41. Localization of the apoptosis-inducing activity of lupus anticoagulant in an annexin V-binding antibody subset
42. High levels of antibodies to annexins V and VI in patients with rheumatoid arthritis
43. Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL
44. Cross reaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus
45. Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction
46. A need for standardization of the anti-endothelial-cell antibody test
47. Antivascular endothelial cell antibodies (AECA). Comparison of the two assay methods and clinical applications
48. Anti-endothelial cell antibodies in sera of patients with autoimmune diseases: Comparison between ELISA and FACS analysis
49. Characterization of anti-endothelial antibodies in patients with rheumatoid arthritis complicated with vasculitis
50. Anticardiolipin antibodies in Horton's disease
51. The incidence of rheumatoid vasculitis in the Norwich health authority
52. Leg ulceration in rheumatoid arthritis
53. Peripheral neuropathy with necrotizing vasculitis in rheumatoid arthritis
54. Factors associated with the development of vasculitis in rheumatoid arthritis: Results of a case-control study
55. Extra-articular rheumatoid arthritis: Prevalence and mortality
56. Catastrophic antiphospholipid syndrome with fatal acute course in rheumatoid arthritis
57. Analyse anatomique et nosologique de 100 cas d'angéites diffuses vues en rhumatologie
58. Antilactoferrin antibodies in patients with rheumatoid arthritis are associated with vasculitis
59. Antineutrophil cytoplasmic antibodies in rheumatoid arthritis patients
60. Incidence, target antigens, and clinical implications of antineutrophil cytoplasmic antibodies in rheumatoid arthritis
61. Antineutrophil cytoplasmic antibodies in rheumatoid arthritis. Characterization and clinical correlations
62. Lipoprotein (a) and anticardiolipin antibodies as risk factors for vascular disease in rheumatoid arthritis
63. Anticardiolipin antibodies in patients with rheumatic diseases
64. Disease distribution of beta2-glycoprotein I-dependent anticardiolipin antibodies in rheumatic diseases
65. Vasculitis in systemic sclerosis: Association with Sjögren's syndrome and the CREST syndrome variant
66. Participation of cryoglobulinemia in the severe peripheral neuropathies of primary Sjögren's syndrome
67. Vasculitis in patients with systemic sclerosis and severe digital ischaemia requiring amputation
68. Anticardiolipin, anticentromere and anti-Scl 70 antibodies in patients with systemic sclerosis and severe digital ischaemia
69. Leucocytoclastic vasculitis as presenting feature of primary Sjögren's syndrome